Pages that link to "Q51528468"

The following pages link to Short-term effects of gastric bypass surgery on circulating ghrelin levels (Q51528468):

Displaying 47 items.

• Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review (Q26780440) (← links)
• Ghrelin and eating disorders (Q26995199) (← links)
• The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity (Q30388925) (← links)
• Changes in neurohormonal gut peptides following bariatric surgery (Q30391329) (← links)
• Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? (Q33789529) (← links)
• Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding (Q33879265) (← links)
• The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery (Q33932609) (← links)
• Ghrelin and metabolic surgery (Q34026487) (← links)
• Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? (Q34589770) (← links)
• Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review (Q34824005) (← links)
• Changes in Gastrointestinal Hormones and Leptin After Roux‐en‐Y Gastric Bypass Surgery (Q34824270) (← links)
• Impact of Sustained Weight Loss Achieved through Roux-en-Y Gastric Bypass or a Lifestyle Intervention on Ghrelin, Obestatin, and Ghrelin/Obestatin Ratio in Morbidly Obese Patients (Q34981837) (← links)
• Physiology of Weight Loss Surgery (Q36055375) (← links)
• Obesity and the role of gut and adipose hormones in female reproduction (Q36507088) (← links)
• Association of ghrelin receptor promoter polymorphisms with weight loss following Roux-en-Y gastric bypass surgery (Q36533912) (← links)
• Role of endogenous ghrelin in growth hormone secretion, appetite regulation and metabolism (Q36695361) (← links)
• Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice (Q36970993) (← links)
• Mechanisms behind the immediate effects of Roux-en-Y gastric bypass surgery on type 2 diabetes (Q37053538) (← links)
• Gut hormones as potential new targets for appetite regulation and the treatment of obesity (Q37057996) (← links)
• The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones (Q37095586) (← links)
• Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass (Q37261091) (← links)
• The mechanisms of weight loss after bariatric surgery. (Q37442590) (← links)
• Obesity, gut hormones, and bariatric surgery. (Q37511828) (← links)
• Energy homoeostasis: The roles of adipose tissue-derived hormones, peptide YY and Ghrelin. (Q37669690) (← links)
• The effect of bariatric surgery on gut hormones that alter appetite (Q37691662) (← links)
• Changes in Ghrelin Levels Following Bariatric Surgery: Review of the Literature (Q37812028) (← links)
• Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus (Q37831911) (← links)
• Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. (Q37862878) (← links)
• Ghrelin, appetite and gastric electrical stimulation (Q37889436) (← links)
• Metabolic surgery-principles and current concepts (Q37922651) (← links)
• Bariatric surgery, bone loss, obesity and possible mechanisms (Q38055242) (← links)
• From gut changes to type 2 diabetes remission after gastric bypass surgeries (Q38095825) (← links)
• The Impact of Ghrelin in Metabolic Diseases: An Immune Perspective (Q42730636) (← links)
• The Sir David Cuthbertson Medal Lecture. Hunting for new pieces to the complex puzzle of obesity (Q44261915) (← links)
• Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects (Q46561401) (← links)
• Short-term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects (Q46937902) (← links)
• Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients. (Q47198263) (← links)
• Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass-induced weight loss (Q47209015) (← links)
• The role of dumping syndrome in weight loss after gastric bypass surgery. (Q47266956) (← links)
• Influence of additional resection of the gastric fundus on excessive weight loss in laparoscopic very very long limb Roux-en-Y gastric bypass (Q47273553) (← links)
• Predictive factors of excess body weight loss 1 year after laparoscopic bariatric surgery (Q47332921) (← links)
• Lung Tissue Volume is Elevated in Obesity and Reduced by Bariatric Surgery. (Q47450148) (← links)
• Gastric bypass surgery may improve beta cell apoptosis with ghrelin overexpression in patients with BMI ≥ 32.5 kg/m(2.). (Q51330636) (← links)
• Effects of laparoscopic gastric band applications on plasma and fundic acylated ghrelin levels in morbidly obese patients (Q51369049) (← links)
• Comparison of serum and salivary ghrelin in healthy adults, morbidly obese, and patients with metastatic carcinoma (Q51402743) (← links)
• Meal suppression of circulating ghrelin is normalized in obese individuals following gastric bypass surgery (Q51491650) (← links)
• Ghrelin levels before and after reduction of overweight due to a low-fat high-carbohydrate diet in obese children and adolescents (Q51520409) (← links)